Exaggerated hypertensive response.
Fenoldopam should be avoided or used at much lower doses if the patient has received a MAO inhibitor.
Source: G&G 14e · p259
D1 receptor agonist, α2 adrenergic receptor agonist · Antihypertensive
Fenoldopam is an agonist for peripheral D1 receptors, leading to vasodilation. It also binds with moderate affinity to α2 adrenergic receptors. It dilates coronary arteries, afferent and efferent arterioles in the kidney, and mesenteric arteries.
Exaggerated hypertensive response.
Fenoldopam should be avoided or used at much lower doses if the patient has received a MAO inhibitor.
Source: G&G 14e · p259
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Clinical effect not specified
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
2 additional low-confidence interactions hidden — those rows lack a documented mechanism or management plan in our sources.
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: KD Tripathi 7e, Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team